![]() ![]() Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Nutrition 21 LLC filed Critical Nutrition -08-08 Assigned to NUTRITION 21 reassignment NUTRITION 21 ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). ![]() Original Assignee Nutrition 21 LLC Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) McCarty Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Lifetime Application number US08/908,819 Inventor Mark F. Google Patents High-dose chromium/biotin treatment of type II diabetesÄownload PDF Info Publication number US5789401A US5789401A US08/908,819 US90881997A US5789401A US 5789401 A US5789401 A US 5789401A US 90881997 A US90881997 A US 90881997A US 5789401 A US5789401 A US 5789401A Authority US United States Prior art keywords biotin chromium chromic tripicolinate diabetes type Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US5789401A - High-dose chromium/biotin treatment of type II diabetes ![]() US5789401A - High-dose chromium/biotin treatment of type II diabetes ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |